Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

17.9K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.9K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.7K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vaccination elicits HIV broadly neutralizing antibodies in primates.

Nature·2026
Same author

Rapid boosting increases germinal center responses to sequential vaccines.

Nature immunology·2026
Same author

Deep learning-enabled scaffolding of spatial arrays of PfCSP epitopes.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Local antibody feedback enforces a checkpoint on affinity maturation in the germinal center and promotes epitope spreading.

Immunity·2026
Same author

Virus glycoprotein nanodisc platform for vaccine analytics.

Nature communications·2026
Same author

DNA origami vaccines program antigen-focused germinal centers.

Science (New York, N.Y.)·2026

Related Experiment Video

Updated: Apr 19, 2026

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

14.9K

Structural and immunogenetic signatures guide CD4-mimetic HIV vaccine development.

Daniel L V Bader1, Claudia T Flynn2, Oleksandr Kalyuzhniy3

  • 1Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Cell Reports
|April 17, 2026
PubMed
Summary

Developing an HIV vaccine requires understanding broadly neutralizing antibodies (bnAbs). This study analyzes VH1-46 bnAbs, revealing diverse structures and identifying classes that can guide future vaccine design for optimal targeting.

Keywords:
CD4-binding siteCD4bsCP: ImmunologyHIVN276 glycan barrierbroadly neutralizing antibody (bnAb)germline-targeting (GT) vaccine designhuman immunodeficiency virusimmunogenetics

More Related Videos

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

13.1K
Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

9.3K

Related Experiment Videos

Last Updated: Apr 19, 2026

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

14.9K
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

13.1K
Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

9.3K

Area of Science:

  • Immunology
  • Structural Biology
  • Vaccine Development

Background:

  • HIV vaccine strategies aim to elicit broadly neutralizing antibodies (bnAbs) targeting the CD4-binding site.
  • These bnAbs are often derived from specific immunoglobulin heavy-chain variable genes, including VH1-2 and VH1-46.

Purpose of the Study:

  • To present an integrated analysis of VH1-46 bnAbs to guide HIV vaccine design.
  • To characterize the structural and immunogenetic features of VH1-46 bnAbs.

Main Methods:

  • In vitro functional studies of VH1-46 bnAbs.
  • Cryo-electron microscopy (cryo-EM) of bnAbs complexed with HIV envelope trimers.
  • Comprehensive structural and immunogenetic analyses.

Main Results:

  • VH1-46 bnAbs utilize diverse light-chain variable genes and LCDR3 lengths found in human repertoires.
  • Unique LCDR3 signatures influence antibody paratope and binding angle.
  • Three distinct VH1-46 bnAb classes (1B2530, CH235, and 561) were identified, with the 561 class having two subtypes.

Conclusions:

  • VH1-46 bnAbs exhibit significant diversity in their structural and immunogenetic properties.
  • Tailoring VH1-46 priming immunogens to specific bnAb classes is crucial for effective vaccine design.
  • The 561 class of VH1-46 bnAbs represents a promising target for germline-targeting vaccine strategies.